William Vickery joins Hybrigenics as Head of Corporate and Business Development

07-Dec-2010 - France

Hybrigenics announced it has hired William Vickery as Head of Corporate and Business Development, a newly created position.

William worked for five years at ExonHit Therapeutics as Senior Director of Business Development. During this time, he negotiated multiple extensions to ExonHit Therapeutics’ strategic partnership with Allergan, secured it’s participation in PharmaCog (the European Innovative Medicines Initiative consortium on Alzheimer’s disease) and in-licensed a breast cancer diagnostic discovered by Gustave Roussy Institute.

Prior to joining ExonHit Therapeutics in 2006 and since 2003, William served as a Business Development Director of Roche Pharmaceuticals in the US. During his tenure, he was responsible for out-licensing and divestiture of Roche-developed assets. He led the Roche strategic alliance teams which established the alliances with Syrrx and Amira. From 2000 to 2003, he held various positions at Roche Pharmaceuticals headquarters in Switzerland, including business development responsibilities for CNS and metabolic diseases. He received an MBA from INSEAD and an engineering degree from HEI (Lille, France).

https://www.bionity.com/en/news/126992/william-vickery-joins-hybrigenics-as-head-of-corporate-and-business-development.html